Understanding Cannabis and Cognitive Safety in Aging Adults
Cannabis cognitive safety in aging adults is a growing concern as more seniors use cannabis for various conditions. Current evidence is limited but suggests complex effects on cognition and memory. Clinicians need to counsel older patients carefully…
Johns Hopkins Study Reveals Cannabis Mental Health Risks
The Johns Hopkins cannabis mental health risks study identifies heightened psychiatric concerns linked to recreational cannabis legalization. This research highlights vulnerable populations facing increased mental health risks. Clinicians should consider…
IGC Pharma Nears Completion of Phase 2 CALMA Trial Enrollment
The phase 2 CALMA trial enrollment by IGC Pharma has reached 80%, marking significant progress in cannabis-derived therapeutic research. This trial aims to establish safety and efficacy data for a novel cannabis pharmaceutical candidate. Clinicians…